HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Fudan University

Conditions

First-line Treatment of Advanced Pancreatic CancerPancreatic Cancer

Phase 3

HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer

RecruitingNCT05751850

Jiangsu HengRui Medicine Co., Ltd.First-line Treatment of Advanced Pancreatic Cancer

Start: 2023-06-13End: 2025-12-30Target: 778Updated: 2024-05-09

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Not yet recruitingNCT06217042

Fudan UniversityPancreatic Cancer

Start: 2024-02-05End: 2028-07-30Target: 524Updated: 2024-01-22